The thirteenth edition of the Pharmapack Europe event will take place on 12-13 February 2014 at Paris Expo, Porte de Versailles. More than 3,000 visitors and 330 exhibitors from over 70 countries will gather in the new exhibition hall to review the latest innovations and trends in packaging and delivery systems for medications and healthcare products.?
For several years, the event was held in the north of Paris, initially at the Cité des Sciences and, subsequently, at the Grande Halle de la Villette, where it grew into a major event. Now, Pharmapack Europe is moving to the Porte de Versailles, in the south of the French capital. This change of location is a natural consequence following the success of the 2013 edition, which drew a record-breaking 3,000 visitors and 305 exhibitors. "As we expect even greater numbers of participants for the 2014 edition, we have opted for a larger space capable of accommodating around 330 exhibitors. In addition, this new site is located at the edge of central Paris and offers easy access, enabling the event to pursue its international development by providing more extensive top-quality services and facilities to suit professionals arriving from throughout the world", explains Aurore Domange, Event Manager of Pharmapack Europe. In this new location, as at previous editions, visitors to the event will find the same convivial atmosphere that has proven so conducive to effective networking and productive discussions of ongoing and forthcoming projects.
Meeting current expectations and planning for the future
As the leading European conference and exhibition in the field of pharmaceutical packaging and drug delivery systems, Pharmapack Europe remains true to its primary objective: to reflect the issues of concern to healthcare industry stakeholders and to showcase the major trends in the sector, both in terms of emerging markets and technological innovation. "The event's logo has thus been updated to highlight the growing importance of delivery systems, in particular for injectable treatments, which account for around 80% of the healthcare products currently in development.?
These systems, which constitute an essential part of a medication and its packaging, represent a market that is growing strongly and driving innovation forward", states Aurore Domange. In keeping with its aim to meet the expectations of the healthcare industry, Pharmapack Europe will offer, once again, an edition packed with new features, as well as a top-quality conference and technical symposium programme alongside a first-rate exhibition.?
The theme for the 2014 edition will be compliance and safety. These topics, which are central to current public healthcare challenges, will be addressed by an international panel of industrial, institutional and academic specialists. It is important to note that the 2014 conference programme will provide an opportunity for patient associations, as well as medication manufacturers, packaging specialists and healthcare professionals (hospital pharmacists, doctors, etc.), to express their needs with respect to the new packaging and delivery solutions put forward. "Pharmapack Europe is a showcase for technology and an incubator for innovations in packaging and drug delivery for healthcare products. The event brings together key healthcare stakeholders and offers the opportunity to consider the trends and innovations of the future, taking into account the difficulties faced by carers, patients, medication manufacturers and providers of solutions, from the design phase through to finished products", emphasises Aurore Domange.
Semi-scientific conferences focused on innovation
The 2014 conference programme will highlight the latest innovations in packaging and drug delivery systems intended to improve compliance and delivery of treatments, as well as the safety of patients and carers. More generally, top-level presentations will provide a comprehensive overview of changes to regulations, new market trends, and technological progress towards more effective solutions in terms of reducing costs and environmental impact. Particular emphasis will be given to innovation in delivery systems for injectables.?
